Blue, I just got back from an Angel investors meeting organized by the investing club I belong to.
The main pitch had a point where it was stressed many times as it is better to have an average product with a very good management than a fantastic product with poor management.
I believe ipci has potentially good products but it lacks execution.
Today I made my last buy to average down since I felt it was almost impossible to get back to where we were just one year ago.
Samsa is right when he says manipulation did an incredible damage, but going into Rexista AdComm with a partner and having Regabatin partnered even before that would have left manipulation without ammunition before even starting.
So the idea that they are a young biotech doesn't assolve them from being terrible managers.
News 
Market Data 
Discover 
